vimarsana.com

Latest Breaking News On - Ciara martin - Page 3 : vimarsana.com

Measles cases soared in Europe to 42,200 last year, almost 45-fold increase on previous year

EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Study results Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia.

EQS-News: Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide

EQS-News: Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenam

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): StudyNewron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide 29.12.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Newron completes enrollment of schizophrenia patie.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.